8-K Announcements
6Feb 25, 2026·SEC
Nov 5, 2025·SEC
Sep 16, 2025·SEC
Hippo Holdings Inc. (HIPO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Hippo Holdings Inc. (HIPO) stock price & volume — 10-year historical chart
Hippo Holdings Inc. (HIPO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Hippo Holdings Inc. (HIPO) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.27vs $0.09+204.0% | $122Mvs $127M-4.7% |
| Q1 2026 | Feb 25, 2026 | $0.24vs $0.21+14.3% | $120Mvs $121M-0.5% |
| Q1 2026 | Feb 24, 2026 | $0.24vs $0.21+14.3% | $120Mvs $121M-0.5% |
| Q4 2025 | Nov 5, 2025 | $0.70vs $0.04+1650.0% | $121Mvs $121M-0.4% |
Hippo Holdings Inc. (HIPO) competitors in Specialty Personal and Pet Insurance — business model, growth, and fundamentals comparison
Hippo Holdings Inc. (HIPO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Hippo Holdings Inc. (HIPO) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Revenue | 34.7M | 51.6M | 91.2M | 119.7M | 209.7M | 372.1M | 468.6M | 479.8M |
| Revenue Growth % | - | 48.7% | 76.74% | 31.25% | 75.19% | 77.44% | 25.93% | 20.77% |
| Medical Costs & Claims | 0 | 35M | 105.9M | 179.1M | 293.1M | 297.8M | 229.9M | 285.6M |
| Medical Cost Ratio % | 0% | 67.83% | 116.12% | 149.62% | 139.77% | 80.03% | 49.06% | 59.52% |
| Gross Profit | 34.7M▲ 0% | 16.6M▼ 52.2% | -14.7M▼ 188.6% | -59.4M▼ 304.1% | -83.4M▼ 40.4% | 74.3M▲ 189.1% | 238.7M▲ 221.3% | 194.2M▲ 0% |
| Gross Margin % | 100% | 32.17% | -16.12% | -49.62% | -39.77% | 19.97% | 50.94% | 40.48% |
| Gross Profit Growth % | - | -52.16% | -188.55% | -304.08% | -40.4% | 189.09% | 221.27% | - |
| Operating Expenses | 106.5M | 159.8M | 352.5M | 265.8M | 179.1M | 101.7M | 175.4M | 78.1M |
| OpEx / Revenue % | 306.92% | 309.69% | 386.51% | 222.06% | 85.41% | 27.33% | 37.43% | 16.28% |
| Depreciation & Amortization | 0 | 6.7M | 11M | 15.2M | 19.8M | 23.2M | 0 | 0 |
| Combined Ratio % | 306.92% | 377.52% | 502.63% | 371.68% | 225.18% | 107.36% | 86.49% | 75.8% |
| Operating Income | -71.8M▲ 0% | -143.2M▼ 99.4% | -367.2M▼ 156.4% | -325.2M▲ 11.4% | -262.5M▲ 19.3% | -27.4M▲ 89.6% | 63.3M▲ 331.0% | 116.1M▲ 0% |
| Operating Margin % | -206.92% | -277.52% | -402.63% | -271.68% | -125.18% | -7.36% | 13.51% | 24.2% |
| Operating Income Growth % | - | -99.44% | -156.42% | 11.44% | 19.28% | 89.56% | 331.02% | - |
| EBITDA | -71.8M | -136.5M | -356.2M | -310M | -242.7M | -4.2M | 63.3M | 116.1M |
| EBITDA Margin % | -206.92% | -264.53% | -390.57% | -258.98% | -115.74% | -1.13% | 13.51% | 24.2% |
| Interest Expense | 0 | 26M | 198.9M | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | -71.8M | -26M | -198.9M | 0 | 0 | 0 | 0 | 0 |
| Pretax Income | -83M▲ 0% | -143.2M▼ 72.5% | -367.2M▼ 156.4% | -325.2M▲ 11.4% | -262.5M▲ 19.3% | -27.4M▲ 89.6% | 63.3M▲ 331.0% | 116.1M▲ 0% |
| Pretax Margin % | -239.19% | -277.52% | -402.63% | -271.68% | -125.18% | -7.36% | 13.51% | 24.2% |
| Income Tax | 100K | -1.8M | 700K | 1.3M | 500K | 1.2M | 700K | 1M |
| Effective Tax Rate % | -0.12% | 1.26% | -0.19% | -0.4% | -0.19% | -4.38% | 1.11% | 0.86% |
| Net Income | -83.1M▲ 0% | -141.5M▼ 70.3% | -371.4M▼ 162.5% | -333.4M▲ 10.2% | -273.1M▲ 18.1% | -40.5M▲ 85.2% | 57.7M▲ 242.5% | 112.5M▲ 0% |
| Net Margin % | -239.48% | -274.22% | -407.24% | -278.53% | -130.23% | -10.88% | 12.31% | 23.45% |
| Net Income Growth % | - | -70.28% | -162.47% | 10.23% | 18.09% | 85.17% | 242.47% | 314.29% |
| EPS (Diluted) | -171.52▲ 0% | -40.68▲ 76.3% | -23.77▲ 41.6% | -14.35▲ 39.6% | -11.58▲ 19.3% | -1.64▲ 85.8% | 2.22▲ 235.4% | 4.27▲ 0% |
| EPS Growth % | - | 76.28% | 41.57% | 39.63% | 19.3% | 85.84% | 235.37% | 305.71% |
| EPS (Basic) | -171.52 | -40.68 | -23.77 | -14.35 | -11.58 | -1.64 | 2.28 | - |
| Diluted Shares Outstanding | 484.49K | 3.48M | 15.48M | 22.75M | 23.58M | 24.7M | 26.01M | 26.35M |
Hippo Holdings Inc. (HIPO) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 170.5M | 979.4M | 1.64B | 1.57B | 1.52B | 1.54B | 1.91B | 2.06B |
| Asset Growth % | - | 474.43% | 67.73% | -4.49% | -2.82% | 1.23% | 23.46% | 91.52% |
| Total Investment Assets | 0 | 56M | 73.1M | 445.9M | 348.8M | 0 | 445.9M | 4M |
| Long-Term Investments | 0 | 56M | 64M | 0 | 0 | 0 | 445.9M | 922.4M |
| Short-Term Investments | 0 | 0 | 9.1M | 445.9M | 348.8M | 0 | 0 | 244.4M |
| Total Current Assets | 23.3M | 0 | 1.15B | 1.47B | 1.4B | 364.6M | 468.4M | 1.76B |
| Cash & Equivalents | 23.3M | 452.3M | 775.6M | 194.5M | 142.1M | 197.6M | 250.1M | 275.4M |
| Receivables | 0 | 192.5M | 365M | 448.3M | 505.9M | 167M | 98.7M | 2.23B |
| Other Current Assets | 0 | -774.2M | 0 | 50M | 53M | 0 | 119.6M | 29.4M |
| Goodwill & Intangibles | 25.3M | 96.4M | 111.6M | 65.7M | 75.7M | 65.1M | 13.8M | 267.6M |
| Goodwill | 1.9M | 47.8M | 53.5M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 23.4M | 48.6M | 58.1M | 65.7M | 75.7M | 65.1M | 13.8M | 83.9M |
| PP&E (Net) | 900K | 0 | 1.1M | 33M | 45.5M | 37.7M | 0 | 32.7M |
| Other Assets | 121M | -152.4M | -175.6M | 4.2M | 6.8M | -85.8M | -445.9M | 9.4M |
| Total Liabilities | 18.2M | 1.18B | 781M | 975.4M | 1.14B | 1.18B | 1.47B | 1.61B |
| Total Debt | 0 | 273M | 0 | 28.9M | 14.8M | 10M | 52.4M | 51.5M |
| Net Debt | -23.3M | -179.3M | -775.6M | -165.6M | -127.3M | -187.6M | -197.7M | -223.9M |
| Long-Term Debt | 0 | 273M | 0 | 0 | 0 | 0 | 47.9M | 47.9M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 18.2M | 0 | 182.6M | 911.7M | 1.07B | 267.9M | 1.35B | 1.5B |
| Accounts Payable | 0 | 96M | 182.6M | 234.8M | 286.4M | 267.9M | 319.3M | 369.1M |
| Deferred Revenue | 0 | 0 | 0 | 341.3M | 419.2M | 0 | 226M | 615.3M |
| Other Current Liabilities | 0 | -103.5M | -182.6M | 323.2M | 348.3M | 0 | 796.8M | 506.5M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | -279.1M | 0 | 13.6M | 43.1M | 892.3M | 55M | 50.7M |
| Total Equity | 118.7M▲ 0% | -199.5M▼ 268.1% | 861.7M▲ 531.9% | 593.5M▼ 31.1% | 384.7M▼ 35.2% | 365.2M▼ 5.1% | 436.1M▲ 19.4% | 448.7M▲ 0% |
| Equity Growth % | - | -268.07% | 531.93% | -31.12% | -35.18% | -5.07% | 19.41% | 87.16% |
| Shareholders Equity | 118.7M | -199.6M | 859.6M | 589.9M | 377.9M | 362.1M | 436.1M | 448.7M |
| Minority Interest | 0 | 100K | 2.1M | 3.6M | 6.8M | 3.1M | 0 | 0 |
| Retained Earnings | -115.1M | -256.6M | -628M | -961.1M | -1.23B | -1.27B | -1.22B | -1.21B |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 100K | 100K | -700K | -7M | -2.9M | -2.7M | 1.8M | -600K |
| Return on Equity (ROE) | -70.01% | - | -112.17% | -45.82% | -55.84% | -10.8% | 14.4% | 27.43% |
| Return on Assets (ROA) | -48.74% | -24.61% | -28.33% | -20.76% | -17.66% | -2.64% | 3.35% | 5.96% |
| Equity / Assets | 69.62% | -20.37% | 52.46% | 37.83% | 25.23% | 23.66% | 22.89% | 21.76% |
| Debt / Equity | - | - | - | 0.05x | 0.04x | 0.03x | 0.12x | 0.12x |
| Book Value per Share | 245.00 | -57.39 | 55.68 | 26.09 | 16.32 | 14.79 | 16.77 | 17.03 |
| Tangible BV per Share | 192.78 | -85.13 | 48.47 | 23.20 | 13.10 | 12.15 | 16.24 | 13.84 |
Hippo Holdings Inc. (HIPO) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -29.1M | -65.4M | -124.5M | -161.5M | -92.4M | 47.5M | 9.2M | 9.2M |
| Operating CF Growth % | - | -124.74% | -90.37% | -29.72% | 42.79% | 151.41% | -80.63% | 543.01% |
| Operating CF / Revenue % | -83.86% | -126.74% | -136.51% | -134.92% | -44.06% | 12.77% | 1.96% | 1.92% |
| Net Income | -83.1M | -141.4M | -367.9M | -326.5M | -273.1M | -28.6M | 57.7M | 112.5M |
| Depreciation & Amortization | 2.9M | 6.7M | 11M | 15.2M | 19.8M | 23.2M | 20.4M | 0 |
| Stock-Based Compensation | 21.9M | 17.2M | 24.3M | 61.9M | 57.5M | 38.2M | 29.3M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.8M | 27.1M | 164.4M | 50.6M | 10.1M | -55.6M | -94M | 47.3M |
| Working Capital Changes | 26.4M | 25M | 43.7M | 37.3M | 93.3M | 70.3M | -4.2M | 0 |
| Cash from Investing | -72.3M | -2.3M | -30M | -405.9M | 57.6M | 30.3M | -11.2M | 42.3M |
| Capital Expenditures | -900K | -400K | -800K | -19.7M | -29.6M | -300K | -100K | -3.6M |
| Acquisitions | -600K | -83.7M | -600K | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | 0 | -16.7M | -26.2M | -793M | -409.6M | -367.8M | -287.6M | -397.7M |
| Sale/Maturity of Investments | 0 | 107.5M | 16.5M | 408.8M | 517.1M | 336.9M | 307.8M | 398.2M |
| Other Investing | -70.8M | -9M | -18.9M | -2M | -20.3M | 61.5M | -31.3M | 45.4M |
| Cash from Financing | 101.4M | 518.1M | 480.8M | -6.8M | -14.6M | -40.1M | 19.3M | 29M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -1.8M | -15.6M | -14.5M | -14.5M |
| Stock Issued | 0 | 0 | 0 | 4.1M | 2.8M | 6.7M | 3.8M | 3.8M |
| Debt Issuance (Net) | 0 | 1000K | 0 | 0 | 0 | 0 | 1000K | 1000K |
| Other Financing | 101.4M | -1.5M | 480.8M | -10.9M | -15.6M | -31.2M | -17.9M | -8.2M |
| Net Change in Cash | 42M▲ 0% | 450.4M▲ 972.4% | 326.3M▼ 27.6% | -574.2M▼ 276.0% | -49.4M▲ 91.4% | 37.7M▲ 176.3% | 17.3M▼ 54.1% | 124.6M▲ 0% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 0 | 42M | 492.4M | 818.7M | 244.5M | 195.1M | 232.8M | 250.1M |
| Cash at End | 42M | 492.4M | 818.7M | 244.5M | 195.1M | 232.8M | 250.1M | 304.8M |
| Free Cash Flow | -30M▲ 0% | -74.8M▼ 149.3% | -141.9M▼ 89.7% | -181.2M▼ 27.7% | -139.1M▲ 23.2% | 47.2M▲ 133.9% | 9.1M▼ 80.7% | 50.1M▲ 0% |
| FCF Growth % | - | -149.33% | -89.71% | -27.7% | 23.23% | 133.93% | -80.72% | 1321.95% |
| FCF Margin % | -86.46% | -144.96% | -155.59% | -151.38% | -66.33% | 12.68% | 1.94% | 10.44% |
| FCF per Share | -61.92 | -21.52 | -9.17 | -7.97 | -5.9 | 1.91 | 0.35 | 0.35 |
Hippo Holdings Inc. (HIPO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Combined Ratio | 377.52% | 502.63% | 371.68% | 225.18% | 107.36% | 86.49% | 75.8% |
| Medical Cost Ratio | 67.83% | 116.12% | 149.62% | 139.77% | 80.03% | 49.06% | 59.52% |
| Return on Equity (ROE) | - | -112.17% | -45.82% | -55.84% | -10.8% | 14.4% | 27.43% |
| Return on Assets (ROA) | -24.61% | -28.33% | -20.76% | -17.66% | -2.64% | 3.35% | 5.96% |
| Equity / Assets | -20.37% | 52.46% | 37.83% | 25.23% | 23.66% | 22.89% | 21.76% |
| Book Value / Share | -57.39 | 55.68 | 26.09 | 16.32 | 14.79 | 16.77 | 17.03 |
| Debt / Equity | - | - | 0.05x | 0.04x | 0.03x | 0.12x | 0.12x |
| Revenue Growth | 48.7% | 76.74% | 31.25% | 75.19% | 77.44% | 25.93% | 20.77% |
Hippo Holdings Inc. (HIPO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Feb 25, 2026·SEC
Nov 5, 2025·SEC
Sep 16, 2025·SEC
Hippo Holdings Inc. (HIPO) stock FAQ — growth, dividends, profitability & financials explained
Hippo Holdings Inc. (HIPO) grew revenue by 25.9% over the past year. This is strong growth.
Yes, Hippo Holdings Inc. (HIPO) is profitable, generating $112.5M in net income for fiscal year 2025 (12.3% net margin).
Hippo Holdings Inc. (HIPO) has a return on equity (ROE) of 14.4%. This is reasonable for most industries.
Hippo Holdings Inc. (HIPO) has a combined ratio of 86.5%. A ratio below 100% indicates underwriting profitability.
Hippo Holdings Inc. (HIPO) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates